Anaesthetic care for sickle cell disease

European Journal of Anaesthesiology

Volumn 18, Issue 3, 2001, Pages 137-150

  Frietsch, T ^a   Ewen, I ^a   Waschke, K F ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anaesthesia; Anaesthetic techniques; Analgesia; Haemoglobin C disease; Haemoglobin SC disease; Haemoglobinopathies; Sickle cell anaemia; Thalassemia; Transfusion

Indexed keywords

ANALGESIC AGENT; CLOTRIMAZOLE; COUMARIN DERIVATIVE; DESMOPRESSIN; ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; MAGNESIUM SALT; OPIATE; SHORT CHAIN FATTY ACID;

ACIDOSIS; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONVALESCENCE; GENE THERAPY; GENERAL ANESTHESIA; HOSPITAL ADMISSION; HUMAN; HYPOTHERMIA; HYPOVOLEMIA; HYPOXEMIA; PATHOGENESIS; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; PROPHYLAXIS; REGIONAL ANESTHESIA; REVIEW; SICKLE CELL ANEMIA; SPLENECTOMY;

ANEMIA, SICKLE CELL; ANESTHESIA; HUMANS;

EID: 0035099752     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0265-0215.2000.00804.x     Document Type: Review

References (81)

1. Sickle cell disease is poorly managed
2. New therapies and approaches to transfusion in sickle cell disease in children
3. Mortality in sickle cell disease. Life expectancy and risk factors for early death
4. Surgery and anesthesia in sickle cell disease
5. Surgery in patients with hemoglobin SC disease
6. Sickle cell anemia: A molecular disease
7. Abnormal human haemoglobins. I. The comparison of normal human and sickle-cell haemoglobins by 'fingerprinting'
8. Sickle cell research
9. Pathogenesis and treatment of sickle cell disease
10. The pathophysiology of the sickle hemoglobinopathies and implications for perioperative management
11. Pathophysiology of sickle cell anemia
12. Determinants of haemoglobin level in steady-state homozygous sickle cell disease
13. Sickle reticulocytes adhere to VCAM-1
14. The anaesthetist's role in acute sickle cell crisis
15. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies
16. Stroke prevention in sickle cell disease
17. Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia
18. Acute chest syndrome in the postoperative sickle cell patient
19. Causes and outcomes of the acute chest syndrome in sickle cell disease
20. The acute chest syndrome in sickle cell disease: Incidence and risk factors
21. Management of sickle cell disease
22. Renal failure in sickle cell anemia
23. Prediction of adverse outcomes in children with sickle cell disease
24. Einfaches perioperatives monitoring der hämoglobin-fraktionen bei sichelzellanämie
25. Thrombosis, megaloblastic anaemia, and sickle cell disease: A unified hypothesis
26. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
27. Cost-effectiveness of hydroxyurea in sickle cell anemia
28. Preliminary report of a toxicity study of hydroxyurea in sickle cell disease
29. Hydroxyurea in two pregnant women with sickle cell anemia
30. Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature
31. Acquired DNA mutations associated with in vivo hydroxyurea exposure
32. Pain measurement in hospitalized adults with sickle cell painful episodes
33. Enhanced thrombin generation in children with sickle cell disease
34. 5′-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells
35. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease
36. A study of induced hyponatremia in the prevention and treatment of sickle-cell crisis
37. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease
38. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease
39. Effect of fluorocarbon emulsions on the mechanical fragility of normal and sickle cells: In vitro studies
40. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study
41. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse
42. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia
43. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions
44. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia
45. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity
46. Transgenic animal models
47. Splenic complications of the sickling syndromes and the role of splenectomy
48. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease
49. Opiates for sickle-cell crisis
50. Alterations in capillary and venous blood gases after regional-block anesthesia
51. Effect of anesthetics on the stability of oxyhemoglobin S
52. Viscosity of sickle disease and trait blood: Changes with anesthesia
53. Use of the tourniquet during surgery in patients with sickle cell hemoglobinopathies
54. Tourniquet use in sickle cell disease patients
55. Fast-track cardiac anesthesia in patients with sickle cell abnormalities
56. Sickle cell anemia and mitral valve replacement. Case report
57. Autologous blood transfusion and intraoperative cell salvage in a patient with homozygous sickle cell disease
58. Anaesthesia and hypothermia in sickle cell disease
59. Patient-controlled analgesia for sickle-cell-related pain
60. The management of pain in sickle cell disease
61. Treating sickle cell pain like cancer pain
62. Selection of adequate substitutes for intravascular volume replacement
63. La transfusion dans la drepanocytose
64. Transfusion management of sickle cell disease
65. Management of sickle cell disease: Recent advances and controversies
66. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
67. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: Perioperative morbidity
68. Hematologic emergencies. Management of transfusion reactions and crises in sickle cell disease
69. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion
70. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke
71. Chronic transfusion programmes in sickle cell disease: Problem or panacea?
72. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
73. Viability and function of stored sickle erythrocytes
74. Long-term cryopreservation of red cells from patients with sickle cell disease
75. Frozen storage of 11 units of sickle cell red cells for autologous transfusion of a single patient
76. Autologous blood transfusion in patients with sickle cell trait
77. Use of the cell saver in patients with sickle cell trait
78. Autotransfusion: A management option for alloimmunized sickle cell patients?
79. Intraoperative autotransfusion for a patient with homozygous sickle cell disease
80. A model for the sickle hemoglobin fiber using both mutation sites
81. Pathophysiology of vasoocclusion